Back to Portfolio
CNH

CNH Industrial

$10.41 12.9B market cap April 15, 2026
CNH Industrial N.V. CNH BUFFETT / MUNGER / KLARMAN SUMMARY
1 SNAPSHOT
Price$10.41
Market Cap12.9B
2 BUSINESS

CNH Industrial is a solid cyclical trough investment offering the world's #2 agricultural equipment franchise at 8x mid-cycle earnings and 1.7x book value. The agricultural cycle is at or near historic trough levels -- North American tractor volumes are down 31% and management guides 2026 as the bottom with recovery starting 2027. Tweedy Browne's massive 113% position increase to 15% of their portfolio (2.98% of CNH shares) provides strong superinvestor validation of the cyclical turnaround thesis. The narrow moat (brand, dealer network, captive finance) is real but not wide enough to prevent earnings volatility -- this is a 2-3 year cyclical trade, not a permanent holding. If the ag cycle recovers as expected, mid-cycle EPS of $1.20-$1.40 implies fair value of $14-$17, representing 35-65% upside. Risk is that the trough extends or deepens, particularly if tariffs and low commodity prices persist. Financial services leverage amplifies both upside and downside.

3 MOAT NARROW

Case IH and New Holland tier-1 ag brands with multi-generational loyalty; independent dealer network creates switching costs; $28.6B captive financial services portfolio locks in customers; #2 global ag equipment position with 45%+ combined US market share (with Deere)

4 MANAGEMENT
CEO: Gerrit Marx (appointed Jan 2022 post-IVECO spinoff)

Average - IVECO spinoff was shareholder-positive, but $244M in tech impairments (Raven, Monarch, Bennamann) show poor acquisition timing. Dividend cut from $0.47 to $0.25 is prudent capital preservation.

5 ECONOMICS
15.5% Op Margin
3.5% ROIC
6.5% ROE
25.4x P/E
0.51B FCF
303% Debt/EBITDA
6 VALUATION
FCF Yield4%
DCF Range10.5 - 14.6

18% below midpoint fair value of $12.65. At trough, trailing P/E is misleadingly high; mid-cycle P/E of 7.4-8.7x is the relevant metric.

7 MUNGER INVERSION
Kill Event Severity P() E[Loss]
Deep agricultural cyclical downturn -- FY2026 guided as 'historic trough' with 5% further industry demand decline, EPS $0.35-$0.45 HIGH - -
Financial services credit deterioration (delinquencies doubled to 3.1%), $244M technology impairments (Raven, Monarch, Bennamann) signal poor M&A MED - -
8 KLARMAN LENS
Downside Case

Deep agricultural cyclical downturn -- FY2026 guided as 'historic trough' with 5% further industry demand decline, EPS $0.35-$0.45

Why Market Right

2026 could be worse than guided if tariffs escalate or commodity prices fall further; Financial services credit losses could accelerate (3.1% delinquency rate climbing); Technology gap vs Deere widening in precision ag and autonomous operations; $244M in tech acquisition impairments raises capital allocation concerns

Catalysts

Agricultural cycle recovery expected 2027 as commodity prices mean-revert and farmer incomes recover; Dealer inventory destocking completion H2 2026 should trigger order inflection; Share buyback acceleration when FCF recovers ($700M+ annual capacity at mid-cycle); Precision agriculture technology monetization via subscription/recurring revenue model; Tariff resolution could unlock farm export demand globally

9 VERDICT WAIT
B Quality Moderate - Complex balance sheet with $26.8B Financial Services debt obscures Industrial health. Industrial ops moderately leveraged with adequate cash. FS delinquencies rising (3.1% vs 1.9%). Investment-grade credit rating prioritized.
Strong Buy$8
Buy$10
Fair Value$14.6

Near accumulate zone at $10.41 vs $10.00 target. Consider starter position (1-2%) at current levels. Add aggressively at $8-9 (Strong Buy zone, 52-week low = $9.00). This is a cyclical trade with 2-3 year holding period -- sell at mid-cycle ($14-17).

🧠 ULTRATHINK Deep Philosophical Analysis

CNH Industrial - Deep Philosophical Analysis

"The stock market is a device for transferring money from the impatient to the patient." -- Warren Buffett

The Core Question: Is This a Business or a Bet?

There is a fundamental distinction in investing between buying a business and making a bet on a cycle. CNH Industrial sits squarely in the latter category, and the honest analyst must acknowledge this upfront rather than pretend otherwise.

When Tweedy Browne builds a 15% portfolio position in CNH -- their largest holding -- they are not saying "this is a wonderful business at a fair price." They are saying "this is a decent business at a cyclical trough price, and the asymmetry favors patience." That distinction matters enormously for how you size the position, set your exit criteria, and manage your psychology during the holding period.

Agricultural equipment manufacturing has a defining characteristic that separates it from the compounders that populate the top of any value investor's watchlist: earnings volatility that makes the business nearly uninvestable at the wrong part of the cycle. CNH earned $1.71 per share at peak (2023) and will earn roughly $0.40 at trough (2026). That is a 4:1 peak-to-trough ratio. No amount of financial engineering, dealer incentives, or precision agriculture technology eliminates the fundamental truth that farmers buy tractors when crop prices are high and defer purchases when crop prices are low.

This is not a criticism. It is simply a recognition of what you are buying. The question is not whether CNH is a great business -- it is not, by Buffett/Munger standards. The question is whether the price compensates you adequately for the cyclicality, and whether the cycle will turn within a reasonable timeframe.

Moat Meditation: Strong Enough to Survive, Not Enough to Compound

Charlie Munger would likely categorize CNH as a business in the "too hard" pile for permanent ownership, but potentially interesting as a cyclical trade. The moat exists -- Case IH and New Holland have genuine brand loyalty among farming communities, the dealer network creates real switching costs, and the captive financial services arm locks in customers through multi-year equipment loans. But the moat is narrow because it does not prevent the business from losing money in a downturn (2020) or earning returns barely above its cost of capital at trough (2025-2026).

Compare this to Deere & Company, which maintained profitability throughout COVID and consistently earns higher margins across the cycle. Deere's moat is wider because its technology leadership (See & Spray, autonomous operations) creates pricing power that CNH lacks. CNH is the Pepsi to Deere's Coca-Cola -- a credible #2 with real market share but structurally lower economics.

The IVECO spinoff in 2022 was a genuine improvement. Removing the low-margin, highly cyclical truck business simplified the portfolio and structurally improved margins. Post-spinoff CNH is a better business than pre-spinoff CNH. But it is still a cyclical industrial, not a compounder.

The $244 million in technology impairments (Raven Industries, Monarch Tractor, Bennamann) tell an important story about capital allocation. Management paid peak-cycle prices for precision agriculture assets that have not delivered value. Munger would note that this is a classic error of cyclical businesses: they generate enormous cash flow at peak, feel emboldened, make acquisitions at peak multiples, and then write them down at trough. The fact that this pattern repeated multiple times in a single year suggests a systematic capital allocation weakness, not a one-off mistake.

The Owner's Mindset: Would Buffett Own This for 20 Years?

No. And this is not a failing of CNH -- it is simply a recognition that deeply cyclical industrials are not Berkshire-style holdings. Buffett has owned one agricultural equipment adjacent business (CTB, Inc., a livestock equipment maker) but has never pursued the major OEMs. The reasons are clear:

  1. Earnings unpredictability: You cannot compound wealth when earnings oscillate between $0.40 and $1.70 per share.
  2. Capital intensity: Equipment manufacturing requires continuous investment in tooling, R&D, and financial services balance sheet.
  3. Commodity dependence: Farm equipment demand is a derivative bet on crop prices, which are driven by weather, trade policy, and factors entirely outside management's control.
  4. Financial leverage: The captive finance arm requires $27B in debt that makes the balance sheet opaque and amplifies risk.

What Buffett would respect about CNH is the Exor/Agnelli family's 27% controlling stake. Family-controlled cyclical businesses tend to make better long-term decisions because they can tolerate short-term pain. The dividend cut from $0.47 to $0.25 is exactly the kind of prudent capital preservation that a family controller enables but a quarterly-earnings-obsessed public company might resist.

Risk Inversion: What Could Destroy This Business?

Inverting the question -- always the right Munger approach -- reveals several paths to permanent capital loss:

  1. Extended agricultural depression (2+ more years): If commodity prices stay depressed through 2028, dealer bankruptcies could accelerate, the financial services book could generate meaningful losses, and CNH's debt capacity could become constrained. This is unlikely but not impossible if trade wars escalate simultaneously with abundant global harvests.

  2. Deere technology dominance: If Deere's autonomous farming platform becomes the industry standard and farmers migrate to an "iPhone-like" ecosystem of Deere hardware + software, CNH could face structural market share loss. This is a 5-10 year risk but a real one.

  3. Financial services blow-up: The $28.6B managed portfolio with rising delinquencies (3.1%) could generate outsized losses in a severe farm recession. Farm debt-to-asset ratios are rising, and younger farmers are more leveraged than their predecessors.

  4. Geopolitical disruption to trade: Agricultural equipment demand is ultimately driven by farm exports. A permanent restructuring of global agricultural trade (e.g., China sourcing all grain from Brazil instead of the US) could structurally reduce North American equipment demand.

None of these are probable in the base case. But the cyclical investor must be honest that trough-buying is not risk-free -- sometimes the trough is deeper and longer than expected, and sometimes the recovery is to a lower peak than the prior cycle.

Valuation Philosophy: Paying the Right Price for the Wrong Time

The central insight of cyclical investing is that you buy when P/E ratios are highest (trough earnings, depressed price) and sell when P/E ratios are lowest (peak earnings, elevated price). This is psychologically difficult because a 25x P/E "looks expensive" even though it reflects $0.41 in trough earnings rather than overvaluation.

At $10.41, CNH is priced at roughly 8x mid-cycle earnings of $1.30. For a #2 global ag equipment franchise with $18B in revenue, 30%+ gross margins, and a credible (if cyclical) business model, 8x mid-cycle earnings provides an adequate margin of safety if your cycle timing is approximately right.

The Tweedy Browne signal is meaningful. This is a firm that has been buying statistically cheap, fundamentally sound businesses for over 50 years. When they build a 15% portfolio position, they have done the work. Their track record is not infallible, but their process is disciplined and their time horizon is appropriate for cyclical recovery trades.

The critical question is not "is CNH cheap?" -- it clearly is relative to history and to mid-cycle earnings power. The question is "how long must I wait, and what is my opportunity cost?" If the agricultural cycle recovers in 2027-2028 as management and industry experts expect, the patient investor should see $14-$17 per share within 2-3 years. That is 35-65% upside from a starting point where the business is not going bankrupt and is still generating positive (if reduced) free cash flow.

The Patient Investor's Path

The disciplined approach to CNH is straightforward:

  1. Size appropriately: This is a 2-4% position, not a 10%+ conviction bet. The cyclicality and narrow moat warrant modest sizing.

  2. Layer in: The stock is near the $10.00 accumulate target but the 52-week low of $9.00 suggests there could be a better entry in H2 2026 if the trough deepens. Start with a 1% position; add at $9 and aggressively at $8.

  3. Set an exit: This is not a permanent holding. When mid-cycle earnings recover and the stock trades at 11-12x mid-cycle EPS ($14-$17), sell. Do not fall in love with a cyclical recovery story.

  4. Monitor the cycle: Track North American equipment retail sales, dealer inventory levels, grain futures, and farm income data. The cycle turn will be visible 6-12 months before it appears in CNH's reported earnings.

  5. Watch the financial services book: If delinquencies continue rising past 4-5%, the risk profile changes materially. This is the canary in the coal mine.

Tweedy Browne has bet that the agricultural cycle turns within their typical 3-5 year holding period. The odds favor them -- agricultural downturns historically last 2-4 years, and this one started in late 2023. But patience is the price of admission, and the investor who buys CNH at trough must be prepared for another 6-12 months of ugly headlines before the recovery materializes.

"In the short run, the market is a voting machine. In the long run, it is a weighing machine." -- Benjamin Graham

The voting machine has pushed CNH to $10.41. The weighing machine says it is worth $12-$15 on mid-cycle economics. The gap between the two is your opportunity -- if you have the temperament to wait.

Executive Summary

CNH Industrial is the world's #2 agricultural equipment manufacturer (Case IH, New Holland Agriculture) and a mid-tier construction equipment player (CASE Construction). The company spun off its truck/bus division (Iveco Group) in January 2022, creating a pure-play equipment and financial services business. CNH is deep in an agricultural cyclical downturn -- FY2025 revenue fell 9% to $18.1B with net income collapsing 59% to $505M ($0.41 EPS). Management guides FY2026 as a "historic trough" with another 5% industry demand decline and EPS of $0.35-$0.45. Tweedy Browne has built CNH into a 15% portfolio position (113% increase in Q4 2025), signaling deep value conviction. At $10.41, the stock trades at 1.70x book and ~8x mid-cycle earnings -- a compelling cyclical trough entry if the agriculture cycle turns as expected in 2027.

PHASE 1: RISK ASSESSMENT

1.1 Business Risk

Cyclicality (HIGH): Agricultural equipment is one of the most cyclical industries in the economy. Farm equipment purchases are discretionary capital expenditures that farmers defer aggressively when commodity prices fall below breakeven. CNH's revenue has ranged from $14.8B (2020 COVID trough) to $24.7B (2023 peak) -- a 67% peak-to-trough swing in just 3 years. The current downturn is driven by:

  • Low grain/oilseed prices well below many farmers' breakeven
  • North American tractor volumes (>140HP) down 31% YoY in Q4 2025
  • Combine volumes down 16% YoY
  • Dealer inventory destocking creating an additional headwind

Competitive Position (MODERATE): CNH is #2 globally behind Deere & Company, with the two holding 45%+ combined U.S. tractor market share. However, Deere has historically earned higher margins and invested more aggressively in precision agriculture technology. AGCO, Kubota, and CLAAS are meaningful competitors. CNH's technology gap vs. Deere is a structural concern.

Financial Services Dependency (MODERATE): CNH's captive financial services arm carries $26.8B in debt to fund $28.6B in managed receivables (equipment financing). While this is standard in the industry (Deere operates identically), rising delinquencies (3.1% >30 days vs. 1.9% prior year) in the current downturn create credit risk. A severe farm recession could trigger meaningful loan losses.

Geographic Concentration: North America and Europe/Middle East/Africa represent the vast majority of revenue. South America (Brazil) is a meaningful but volatile contributor. Limited Asia exposure vs. Kubota.

1.2 Balance Sheet Risk

Industrial Operations:

  • Cash: $3.2B (corporate level)
  • Industrial debt: Modest (majority of $27B is Financial Services)
  • Goodwill: $3.6B (8.4% of assets)
  • Inventory: $4.7B (down from $5.5B peak -- destocking in progress)

Financial Services (Consolidated):

  • Total debt: $26.8B (Financial Services funded debt)
  • Total assets: $42.7B
  • Equity: $7.7B
  • Leverage: 5.5x assets/equity (standard for equipment financing)

Assessment: The balance sheet is complex due to financial services consolidation. Industrial operations themselves are moderately leveraged. The financial services book is investment-grade funded. Delinquency increase from 1.9% to 3.1% bears watching but is manageable.

1.3 Impairment & Write-down Risk

FY2025 saw meaningful write-downs:

  • Raven IPR&D impairment: $123M (precision agriculture acquisition)
  • Monarch Tractor investment impairment: $62M
  • Bennamann IPR&D impairment: $49M
  • New Holland T6.180 write-down: $10M

Total: ~$244M in impairments, reflecting aggressive technology acquisition strategy that has not fully paid off. This suggests management's precision agriculture investments have been value-destructive so far.

1.4 Risk Rating: MODERATE-HIGH

The cyclical risk is real and already materializing. Financial services leverage amplifies downside. However, this is a well-known cyclical pattern in ag equipment, and trough-buying has historically been rewarded.

PHASE 2: FINANCIAL ANALYSIS

2.1 Income Statement (5-Year)

Year Revenue ($B) Gross Margin Op Income ($B) Net Income ($M) EPS
2025 18.10 31.5% 2.81 505 $0.41
2024 19.84 32.7% 3.85 1,246 $0.99
2023 24.69 31.8% 4.95 2,275 $1.71
2022 23.55 29.6% 4.36 2,029 $1.48
2021 19.49 27.7% 3.30 1,723 $1.35
2020 14.78 24.5% 1.84 (493) ($0.28)

Key Observations:

  • Revenue down 27% from 2023 peak to 2025, with 2026 guided another 4% lower
  • Peak-cycle EPS was $1.71 (2023); trough EPS is $0.41 (2025), guided $0.35-$0.45 (2026)
  • Gross margins improved from 24.5% (2020) to 31.5% (2025) -- structural improvement from IVECO spinoff and mix shift
  • The 2020 loss included pre-IVECO truck business (lower margin, higher cyclicality)

Normalized/Mid-Cycle Earnings Estimate:

  • Average EPS 2021-2025: $1.19
  • Average EPS 2022-2024 (excluding extremes): $1.39
  • Post-IVECO mid-cycle EPS estimate: $1.20-$1.40
  • At $10.41, mid-cycle P/E = 7.4x-8.7x

2.2 Segment Performance (FY2025)

Segment Revenue EBIT Margin (Adj) Trend
Agriculture $12.39B (down 12%) 6.2% (vs 10.5%) Declining
Construction $2.96B (down 3%) 2.3% (vs 5.5%) Declining
Financial Services $2.75B Positive but stressed Delinquencies rising

Agriculture is 81% of Industrial revenue and drives the cycle.

2.3 Cash Flow Analysis

Year Operating CF ($B) CapEx ($B) Ind FCF ($M) Dividends ($M) Buybacks ($M)
2025 2.54 0.54 513 333 100
2024 1.97 1.19 (401) 607 702
2023 0.91 1.20 N/A 538 652
2022 0.56 1.00 N/A 423 153
2021 4.08 0.92 N/A 188 0

Note: Industrial Free Cash Flow (management's key metric) was $513M in FY2025 vs. negative $401M in FY2024 -- a massive improvement driven by inventory destocking and reduced capex. 2026 guidance: $150-$350M.

Capital Allocation:

  • Dividend: $0.25/share (FY2025), down from $0.47 (FY2024) -- 2.4% yield at current price
  • Buybacks: $100M (FY2025), $702M (FY2024) -- slowing as cash flow tightens
  • Priority: Preserve investment-grade rating, then return "substantially all" Industrial FCF

2.4 Return on Equity

Year Equity ($B) ROE ROIC (est)
2025 7.73 6.5% ~3.5%
2024 7.65 16.3% ~8.5%
2023 8.03 28.3% ~14.8%
2022 6.93 29.3% ~15.6%
2021 6.78 25.4% ~12.5%

Mid-cycle ROE: ~16-20% -- adequate but not exceptional. The financial services leverage inflates ROE. Industrial-only ROE is lower.

FAILS Buffett 15% ROE Test at Trough. Passes on a mid-cycle basis.

2.5 R&D Investment

R&D spending: $1.025B (2025), $924M (2024), $1.041B (2023) -- 5.7% of revenue. This is meaningful investment in precision agriculture, autonomous driving, and electrification. However, the Raven/Monarch/Bennamann impairments suggest technology M&A has been poorly timed or overpriced.

PHASE 3: MOAT ASSESSMENT

3.1 Moat Sources

Brand Recognition (MODERATE): Case IH and New Holland are tier-1 agricultural brands with multi-generational farmer loyalty, particularly in North America and Europe. However, neither brand has the same dealer density or brand premium as John Deere. Farmers often describe themselves as "Deere families" or "Case families" -- switching costs are real but not as strong as the market leader.

Dealer Network (MODERATE): CNH operates through independent dealers who represent a meaningful switching cost. However, dealer profitability in the downturn is under pressure, and CNH's dealer network is smaller and less productive than Deere's.

Financial Services (MODERATE): Captive financing creates customer lock-in (farmers often finance equipment through the manufacturer). CNH Financial Services had $28.6B in managed receivables. This creates recurring revenue but also credit risk.

Product Breadth (MODERATE): Full-line capability from sub-compact to large row-crop tractors, combines, sprayers, hay/forage, and precision ag. However, Deere leads in technology integration (See & Spray, autonomous operations).

Scale (MODERATE): #2 global position provides manufacturing and procurement scale advantages vs. smaller competitors (AGCO, Kubota in certain segments). But #2 to Deere means lower margins in R&D amortization and dealer support.

3.2 Moat Width: NARROW

CNH has real competitive advantages in brand, dealer network, and financial services, but none are wide enough to create sustained excess returns. The business earned negative income in 2020 and will earn only ~$0.40 EPS in the current trough. A wide-moat business should not lose money in a recession. Mid-cycle ROE of 16-20% (aided by financial leverage) is adequate but below the 25%+ threshold of a truly advantaged business.

3.3 Moat Trend: STABLE

Precision agriculture investments (Raven acquisition) have not yet differentiated CNH vs. Deere's technology leadership. The IVECO spinoff was positive (simplified portfolio, higher margins). But Deere continues to outinvest in autonomous and precision technology.

3.4 Competitive Comparison

Metric CNH Deere (DE) AGCO (AGCO)
Revenue (FY25) $18.1B ~$40B ~$10B
Op Margin (peak) 20% 25%+ 12%
Market Position #2 #1 #3
Tech Leadership Lagging Leading Niche
Mid-cycle P/E 7-9x ~14x ~10x

PHASE 4: VALUATION & SYNTHESIS

4.1 Valuation Methods

Method 1: Mid-Cycle P/E

  • Mid-cycle EPS: $1.20-$1.40 (post-IVECO, post-share buybacks)
  • Appropriate mid-cycle P/E: 10-12x (cyclical industrial, #2 player, narrow moat)
  • Fair value range: $12.00-$16.80
  • Current $10.41 = 23-38% discount to fair value

Method 2: Price-to-Book

  • Book value/share: $6.22
  • Mid-cycle P/B for 16% ROE cyclical: 1.5-2.0x book
  • Fair value range: $9.33-$12.44 (on book)
  • At 1.70x book, within fair range

Method 3: Industrial EV/EBITDA

  • Industrial EBITDA (mid-cycle): ~$3.0-$3.5B
  • Consolidated EV: $12.9B mkt cap + $26.8B debt - $3.2B cash = ~$36.5B
  • EV/EBITDA (consolidated): ~13.8x (inflated by financial services debt -- must isolate Industrial)
  • Industrial-only: Likely 6-8x mid-cycle

Method 4: Dividend Yield Support

  • At normalized $0.40-$0.50 dividend: 3.8-4.8% yield at current price
  • Decent yield floor but not compelling standalone

4.2 Fair Value Summary

Method Low Mid High
Mid-cycle P/E $12.00 $14.40 $16.80
P/B (reported) $9.33 $10.89 $12.44
Blended $10.50 $12.65 $14.60

Intrinsic value estimate: $11-$15 with midpoint $12.65. At $10.41, CNH trades at a **18% discount to midpoint fair value**.

4.3 Entry Prices

  • Strong Buy: $8.00 (6.5x mid-cycle PE, 1.3x book, 30%+ margin of safety)
  • Accumulate: $10.00 (8x mid-cycle PE, 1.6x book, ~20% margin of safety)
  • Current: $10.41 (8.4x mid-cycle PE, 1.7x book, 18% margin of safety)

4.4 Tweedy Browne Signal

Tweedy Browne's 113% position increase to 2.98% of CNH shares outstanding (15% of their portfolio) is a strong conviction signal. Tweedy Browne has a 50+ year track record of buying undervalued, cyclically depressed, high-quality businesses. Their commentary explicitly describes CNH as "significantly undervalued" despite near-term ag cycle headwinds. This is exactly the type of contrarian, deep-value, cyclical trough investment Tweedy specializes in.

However: Tweedy Browne's average cost basis is likely above current levels (they increased at higher prices through 2025). Their conviction does not guarantee the cycle turns on schedule. The 2026 trough guidance ($0.35-$0.45 EPS) could be revised lower if tariffs or commodity prices worsen further.

4.5 Catalysts

Positive:

  1. Agricultural cycle recovery expected 2027 -- commodity prices mean-revert, farmer incomes recover
  2. Dealer inventory destocking completion (H2 2026) -- orders should inflect
  3. Share buyback acceleration when FCF recovers ($700M+ annual capacity at mid-cycle)
  4. Precision agriculture technology monetization (subscription/recurring revenue model)
  5. Tariff resolution could unlock farm export demand

Negative:

  1. 2026 could be worse than guided if tariffs escalate or commodity prices fall further
  2. Financial services credit deterioration (delinquencies already rising)
  3. Technology gap vs. Deere widening
  4. Management impairment track record raises capital allocation concerns

4.6 Investment Thesis

CNH Industrial is a solid cyclical trough investment. At $10.41, you are buying the world's #2 agricultural equipment franchise at roughly 8x mid-cycle earnings, near the historical trough valuation. Tweedy Browne's massive position increase provides superinvestor validation. The risk is that the agricultural downturn extends beyond 2026, which management already calls a "historic trough." If the cycle recovers in 2027 as expected, CNH could earn $1.20-$1.40 per share and trade at $14-$17 within 2-3 years, representing 35-65% upside.

The bear case: CNH is a narrow-moat #2 player in a deeply cyclical industry with financial services leverage that amplifies both upside and downside. It is not a compounder. It is not a business you want to own for 20 years. It is a cyclical trade where you buy near trough and sell near mid-cycle. The $244M in technology impairments suggests management has not been brilliant capital allocators. And at 1.7x book, you are not getting a balance-sheet bargain -- just a reasonable cyclical entry.

VERDICT

WAIT -- Near Accumulate Level

CNH at $10.41 is near the $10.00 accumulate threshold. The stock is in the zone where Tweedy Browne has been aggressively buying. However, with 2026 guided as a "historic trough" and EPS potentially dipping to $0.35, there is downside risk to the $8-9 range (52-week low is $9.00). The prudent move is to establish a starter position at current levels and add more aggressively if the stock reaches $8-9.

This is a CYCLICAL TRADE, not a long-term compounder. Buy at trough, sell at mid-cycle. Target 2-3 year holding period.

Action Price P/E (mid-cycle) P/B Margin of Safety
Strong Buy $8.00 6.5x 1.3x 37%
Accumulate $10.00 8.0x 1.6x 21%
Current $10.41 8.4x 1.7x 18%
Fair Value (mid) $12.65 10.2x 2.0x 0%

Analysis based on: AlphaVantage financial data, CNH FY2025 8-K filing (Feb 17, 2026), company investor relations, web search data. No analyst reports used.